← Animal Health Institute
FDANonrulemakingFDA-2020-D-1402

Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs; Draft Guidance for Industry; Availability

RIN
—
Last modified
Oct 6, 2021
Comment window
closed 2114d ago
Animal Health Institute filings
1

Activity

Animal Health Institute filed 1 comment on this docket between Oct 15, 2020 and Oct 15, 2020. 0 other organizations filed here. The comment window closed 2114d ago.

What Animal Health Institute filed (1)

Oct 15, 2020· Comment from Animal Health Institute (AHI)· FDA-2020-D-1402-0012

The ANIMAL HEALTH INSTITUTE (AHI) appreciates the opportunity to comment on Guidance for Industry #267: Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →